Antitumor Activity and Biochemical Effects of Cyclopentenyl Cytosine in Mice

Cancer Research

Volumn 46, Issue 7, 1986, Pages 3325-3329

  Moyer, James D ^a   Malinowski, Nancy M ^a   Treanor, Susan P ^a   Marquez, Victor E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4,5 DIHYDROXY 3 HYDROXYMETHYL 2 CYCLOPENTEN 1 YL)CYTOSINE; CYTARABINE; CYTIDINE TRIPHOSPHATE; RADIOISOTOPE;

1 (4,5 DIHYDROXY 3 HYDROXYMETHYL 2 CYCLOPENTEN 1 YL)URACIL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; DRUG EFFICACY; DRUG INTERACTION; DRUG SENSITIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA; LYMPHATIC SYSTEM; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY;

ANIMAL; CELLS, CULTURED; CYTIDINE; CYTOSINE NUCLEOTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; LEUKEMIA L1210; LEUKEMIA P388; MELANOMA; MICE; NEOPLASMS, EXPERIMENTAL;

EID: 0022654279     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Arita, M., Adachi, K., Sawai, H., and Ohno, M. Enantioselective synthesis of new analogues of neplanosin A. Nucleic Acids Symp. Ser., 12; 25-30, 1983.
2. Lim, M.-I., Moyer, J. D., Cysyk, R. L., and Marquez, V. E. Cyclopente- nyluridine and cyclopentenylcytidine analogues as inhibitors of uridine-cytidine kinase. J. Med. Chem., 27: 1536-1538, 1984.
3. Ohno, M. Enantioselective synthesis of carbocyclic nucleosides by enzymatic approach and the anticancer activities. Nucleosides & Nucleotides 4:21-28, 1985.
4. Glazer, R. I., Knode, M. C., Lim, M.-I., and Marquez, V. E. Cyclopentenyl cytidine analogue. An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells. Biochem. Pharmacol., 24:2535-2539,1985.
5. Glazer, R. I., Cohen, M. B., Hartman, K. D., Knode, M. C., Lim, M.-L., and Marquez, V. E. Induction uof differentiation in human promyelocytic leukemia cell line HL-60 by the CTP synthetase inhibitor, cyclopentenyl cytidine analogue. Biochem. Pharmacol., in press, 1986.
6. Weber, G., Shiotani, T., Kizaki, H., Tzeng, D., Williams, J. C., and Gladstone, N. Biochemical strategy of the genome as expressed in regulation of pyrimidine metabolism. Adv. Enzyme Regul., 16:3-19,1978.
7. Khym, J. X. An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchanges. Clin. Chem., 21: 1245-1252, 1975.
8. Brockman, R. W., Shaddix, S. C., Williams, M., Nelson, J. A., Rose, L. M., and Schabel, F. M., Jr. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine. Ann. NY Acad. Sci., 255: 501-521,1975.
9. Pogolotti, A. L., Jr., and Santi, D. V. High pressure liquid chromotography- ultraviolet analysis of intracellular nucleotides. Anal. Biochem., 126: 335-345,1982.
10. Shannon, W. M., Arnett, G., Westbrook, L., Shealy, Y. F., O’Dell, C. A., and Brockman, R. W. Evaluation of carbodine, the carbocyclic analog of cytidine and related carbocyclic analogs of pyrimidine nucleosides for antiviral activity against human influenza type A viruses. Antimicrob. Agents Chemother., 20:769-776,1981.
11. Shealy, Y. F., and O'Dell, C. A. The carbocyclic analog of cytidine, synthesis and antineoplastic activity. J. Heterocycl. Chem., 13: 1353-1354,1976.